KL
ZVSA

KIM LLC’s ZyVersa Therapeutics ZVSA Stock Holding History

KIM LLC’s Portfolio ZVSA Stock Details ZVSA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-1,000
Closed -$3.5M – 652
2022
Q3 		$3.5M Hold
1,000
– – 0.16% 159
2022
Q2 		$3.48M Buy
+1,000
New +$3.48M 0.17% 162

Other funds holding ZVSA

Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
CL
CSS LLC Chicago, Illinois $2.57B AUM 67.1% 1-Year Est. Return

KIM LLC's ZVSA Position: Q4 2022 in Review

KIM LLC sold out of ZyVersa Therapeutics (ZVSA) in Q4 2022, closing a stake of 1,000 shares — an estimated $3.5M sold.

KIM LLC first reported a position in ZVSA in Q2 2022 and held it in 2 quarters. The position peaked at $3.5M in Q3 2022. 2 funds tracked by Wall St. Rank hold ZVSA as of Q4 2022.

  • KIM LLC reported no remaining ZyVersa Therapeutics position as of Q4 2022 after selling out during the quarter.
  • KIM LLC sold 1,000 ZyVersa Therapeutics shares in Q4 2022, an estimated $3.5M.
  • KIM LLC first reported a position in ZyVersa Therapeutics in Q2 2022 and held it in 2 quarters.
  • KIM LLC's ZyVersa Therapeutics position peaked at $3.5M in Q3 2022.
  • 2 funds tracked by Wall St. Rank held ZyVersa Therapeutics as of Q4 2022.

Based on KIM LLC's 13F filing for Q4 2022, filed 14 Feb 2023.